hydroxyurea and stavudine

hydroxyurea has been researched along with stavudine in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	19 (40.43)	18.2507
2000's	19 (40.43)	29.6817
2010's	8 (17.02)	24.3611
2020's	1 (2.13)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Ahluwalia, GS; Gao, WY; Johns, DG; Mitsuya, H	1
Chiang, Y; Drake, RR; Govindarajan, R; Hume, SD; Krisa, S; McMasters, R; Munshi, NC; Rechtin, TM; Saylors, RL	1
Loesch, K; Nokta, M; Pollard, RB; Rossero, R	1
Bernasconi, E; Bucher, HC; Hirschel, B; Iten, A; Leduc, D; Malinverni, R; Opravil, M; Perrin, LH; Rutschmann, OT; Sudre, P; Vernazza, PL; Yerly, S	1
Nichols, J; Nokta, M; Pollard, RB; Rosenbaum, M; Rossero, R	1
Back, DJ; Barry, MG; Henry-Mowatt, JS; Hoggard, PG; Kewn, S; Sales, SD; Veal, GJ	1
Hirschel, B; Marchal, F; Opravil, M; Perrin, L; Rutschmann, OT; Yerly, S	1
Alexander, CS; Harrigan, PR; Mo, T; Montaner, JS; Raboud, JM; Rae, S; Rouleau, D; Zala, C	1
Keruly, JC; McArthur, JC; Moore, RD; Wong, WM	1
Cepeda, JA; Wilks, D	1
Bernasconi, E; Bucher, H; Hirschel, B; Iten, A; Malinverni, R; Opravil, M; Perrin, LH; Rutschmann, OT; Vernazza, PL; Yerly, S	1
Johnson, D	1
Bernasconi, E; Bucher, HC; Fagard, C; Hirschel, B; Ledergerber, B; Leduc, D; Malinverni, R; Opravil, M; Perrin, L; Rutschmann, OT; Telenti, A; Vernazza, PL	1
Calles, NR; Kline, MW; Schwarzwald, H; Simon, C	1
Busch, M; Hecht, FM; Kahn, J; Levy, JA; Martinez-Marino, B; Ong, JC; Stranford, SA	1
Chaisson, RE; Keruly, JC; Moore, RD	1
Falkenberg, J; Gilden, D; Torres, G	1
Davis, B; Zachary, KC	1
Levin, J	1
Cahn, P; Federico, A; Kijak, G; Montaner, JS; Ochoa, C; Perez, H; Salomon, H; Zala, C	1
Bendele, RA; Richardson, FC	1
Andron, L; Asmuth, DM; Grady, JJ; Green, S; McKinsey, DS; Pollard, RB; Rossero, R	1
Dogruel, M; Gibbs, JE; Thomas, SA	1
Bower, M; Gazzard, B; Mandalia, S; Nelson, M; Orkin, C; Pozniak, A; Stebbing, J	1
Barasolo, G; Castelli, F; D'Aquila, R; Foli, A; Lisziewicz, J; Lori, F; Maggiolo, F; Maserati, R; Migliorino, M; Pan, A; Paolucci, S; Scudeller, L; Tinelli, C; Tomasoni, L	1
Murphy, RL; Parker, RA; Redfield, RR; Reisler, RB	1
Asmuth, D; Bakare, N; Blick, G; Farthing, C; Foli, A; Frank, I; Greiger, P; Groff, A; Herman, D; Lisziewicz, J; Lori, F; Lova, L; Norris, D; Peterson, D; Pollard, RB; Rashbaum, B; Schrader, S; Shalit, P; Tennenberg, A; Whitman, L	1
Cahn, P; Salomón, H; Zala, C	1
Lisziewicz, J; Lori, F	1

Reviews

2 review(s) available for hydroxyurea and stavudine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Hydroxyurea: overview of clinical data and antiretroviral and immunomodulatory effects. Antiviral therapy, 1999, Volume: 4 Suppl 3 Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine	1999

Trials

12 trial(s) available for hydroxyurea and stavudine

Article	Year
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study. AIDS (London, England), 1998, May-28, Volume: 12, Issue:8 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Middle Aged; Prospective Studies; RNA, Viral; Stavudine; Switzerland; Viremia	1998
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study. The Journal of infectious diseases, 1999, Volume: 180, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Lymph Nodes; RNA, Viral; Stavudine; Viral Load	1999
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine. The Journal of infectious diseases, 2000, Volume: 181, Issue:2 Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Lamivudine; Logistic Models; Mutation; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine	2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study. Antiviral therapy, 1998, Volume: 3 Suppl 4 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Synergism; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Hydroxyurea; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine	1998
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study. AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14 Topics: Anti-HIV Agents; Diarrhea; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studies; HIV Infections; HIV-1; Humans; Hydroxyurea; Nausea; Peripheral Nervous System Diseases; Stavudine	2000
Hydroxyurea for HIV infection. AIDS clinical care, 1998, Volume: 10, Issue:4 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; DNA Replication; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Viral Load	1998
Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection. Journal of acquired immune deficiency syndromes (1999), 2002, Apr-01, Volume: 29, Issue:4 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Hydroxyurea; Male; Middle Aged; Nevirapine; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viremia	2002
Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. International journal of STD & AIDS, 2003, Volume: 14, Issue:5 Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Hydroxyurea; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viral Load; Zidovudine	2003
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART). The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:3 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Hydroxyurea; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Phenotype; Salvage Therapy; Stavudine; Treatment Outcome; Viral Load	2004
Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions. Antiviral therapy, 2004, Volume: 9, Issue:1 Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; HIV-1; Humans; Hydroxyurea; Indinavir; Italy; RNA, Viral; Stavudine; Time Factors; Viral Load; Viremia	2004
Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned. Journal of acquired immune deficiency syndromes (1999), 2005, Jun-01, Volume: 39, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Didanosine; Drug Therapy, Combination; HIV-1; Humans; Hydroxyurea; Incidence; Indinavir; National Institutes of Health (U.S.); Pancreatitis; Reverse Transcriptase Inhibitors; Stavudine; United States	2005
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency. AIDS research and human retroviruses, 2005, Volume: 21, Issue:4 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV; HIV Infections; Humans; Hydroxyurea; Male; RNA, Viral; Stavudine; Viral Load; Viremia	2005

Other Studies

33 other study(ies) available for hydroxyurea and stavudine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis. Molecular pharmacology, 1996, Volume: 50, Issue:1 Topics: Amides; Biotransformation; Biphenyl Compounds; Cell Line; Deoxyguanosine; Floxuridine; HIV; HIV Reverse Transcriptase; HIV-1; Humans; Hydroxyurea; Kinetics; Methotrexate; Models, Biological; Phosphorylation; Pyrazoles; Reverse Transcriptase Inhibitors; Ribonucleosides; Ribose; RNA-Directed DNA Polymerase; Stavudine; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured	1996
Metabolism and activities of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine in herpesvirus thymidine kinase transduced T-lymphocytes. Antiviral research, 1997, Volume: 35, Issue:3 Topics: Acyclovir; Cell Line; Dose-Response Relationship, Drug; Ganciclovir; Genetic Therapy; Growth Inhibitors; Herpesvirus 1, Human; HIV-1; Humans; Hydroxyurea; Nucleosides; Stavudine; Substrate Specificity; T-Lymphocytes; Thymidine Kinase; Zalcitabine; Zidovudine	1997
Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea. AIDS research and human retroviruses, 1997, Dec-10, Volume: 13, Issue:18 Topics: Adult; Anti-HIV Agents; Antigens, CD; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Hydroxyurea; Kinetics; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Reverse Transcriptase Inhibitors; Solubility; Stavudine; Tumor Necrosis Factor-alpha; Viremia	1997
Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations. AIDS research and human retroviruses, 1999, Feb-10, Volume: 15, Issue:3 Topics: Adult; Anti-HIV Agents; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Didanosine; Drug Therapy, Combination; Female; Flow Cytometry; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Hydroxyurea; Immunologic Memory; Leukocyte Common Antigens; Lymphocyte Activation; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Stavudine; T-Lymphocyte Subsets; Viral Load	1999
Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro. AIDS research and human retroviruses, 1999, Jun-10, Volume: 15, Issue:9 Topics: Anti-HIV Agents; Deoxyadenine Nucleotides; Didanosine; Dideoxynucleotides; Drug Interactions; Guanosine; Humans; Hydroxyurea; Inosine; Intracellular Fluid; Lamivudine; Pentoxifylline; Stavudine; U937 Cells; Zidovudine	1999
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS (London, England), 2000, Feb-18, Volume: 14, Issue:3 Topics: Adult; Aged; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Hydroxyurea; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine	2000
Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection. AIDS (London, England), 2000, Feb-18, Volume: 14, Issue:3 Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine	2000
Principles of treating HIV. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2000, Volume: 90, Issue:3 Topics: Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Protease Inhibitors; Randomized Controlled Trials as Topic; Stavudine; Treatment Failure; Viral Load	2000
Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine. The Pediatric infectious disease journal, 2000, Volume: 19, Issue:11 Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Female; HIV Infections; Humans; Hydroxyurea; Infant; Male; Pilot Projects; RNA, Viral; Stavudine	2000
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proceedings of the National Academy of Sciences of the United States of America, 2001, Jan-16, Volume: 98, Issue:2 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Depression, Chemical; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Immunity, Cellular; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Refusal; Viral Load; Viremia; Zidovudine	2001
Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs. AIDS (London, England), 2001, Mar-30, Volume: 15, Issue:5 Topics: Adult; Amylases; Anti-HIV Agents; Didanosine; Female; HIV Infections; HIV-1; Humans; Hydroxyurea; Incidence; Lipase; Longitudinal Studies; Male; Pancreatitis; Reverse Transcriptase Inhibitors; Stavudine; United States; Zidovudine	2001
Update on clinical trials of combination therapies for HIV infection. NIAID AIDS agenda, 1995 Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Lamivudine; RNA-Directed DNA Polymerase; Stavudine; Zalcitabine; Zidovudine	1995
Dethroning AZT. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1997, Volume: 11, Issue:2 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Lamivudine; Oxazines; Stavudine; Viral Load; Zidovudine	1997
Drug research shows easier dosing, new combinations are making gains. AIDS alert, 1998, Volume: 13, Issue:4 Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Combinations; Drug Therapy; Drug Therapy, Combination; Enzyme Inhibitors; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Salvage Therapy; Stavudine; United States; Zidovudine	1998
Hydroxyurea for HIV? Treatment review, 1998,Spring, Issue:No 28 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; DNA; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Stavudine	1998
Hydroxyurea - new observations. Project Inform perspective, 1998, Issue:24 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Indinavir; Nucleic Acid Synthesis Inhibitors; Stavudine; Viral Load; Virus Replication	1998
Interrupting HAART; Hydroxyurea; five+ drug therapy - report from the RIGHT Conference. AIDS treatment news, 1999, May-07, Issue:No 318 Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Nucleic Acid Synthesis Inhibitors; Stavudine	1999
Extended warning on Didanosine-related pancreatitis. Research initiative, treatment action : RITA, 1999, Volume: 5, Issue:5 Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Indinavir; Nucleic Acid Synthesis Inhibitors; Pancreatitis; Stavudine	1999
ddI, d4T, Hydroxyurea: new pancreatitis warning. AIDS treatment news, 1999, Nov-19, Issue:No 331 Topics: Anti-HIV Agents; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Nucleic Acid Synthesis Inhibitors; Pancreatitis; Stavudine; United States Food and Drug Administration	1999
Adefovir nephrotoxicity and mitochondrial DNA depletion. Human pathology, 2002, Volume: 33, Issue:5 Topics: Adenine; Antiviral Agents; Clinical Trials, Phase III as Topic; Cyclooxygenase Inhibitors; DNA, Mitochondrial; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Kidney Tubules; Mitochondria; Organophosphonates; Renal Insufficiency; Stavudine	2002
Hydroxyurea transport across the blood-brain and blood-cerebrospinal fluid barriers of the guinea-pig. Journal of neurochemistry, 2003, Volume: 87, Issue:1 Topics: Animals; Anti-HIV Agents; Blood-Brain Barrier; Carbon Radioisotopes; Cerebrospinal Fluid; Choroid Plexus; Guinea Pigs; Hydroxyurea; Mannitol; Perfusion; Pituitary Gland; Stavudine; Telencephalon; Time Factors; Tritium	2003
Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea. Antiviral therapy, 1999, Volume: 4 Suppl 3 Topics: Acute Disease; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; HIV Infections; Humans; Hydroxyurea; Nevirapine; Pilot Projects; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome	1999